Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis

Jason Wieboldt, Louis Atallah, Julia L. Kelly, Dinesh Shrikrishna, Khin M. Gyi, Benny Lo, Guang Yang, Diana Bilton, Michael I. Polkey, Nicholas S HopkinsonJournal of Cystic Fibrosis 2012 · DOI

TL;DR

This study investigated how acute exacerbations impact skeletal muscle strength and physical activity in cystic fibrosis (CF) patients. They found that quadriceps strength significantly decreases during exacerbations but recovers within a month, while respiratory muscle strength remains largely unaffected. This suggests that while exacerbations are taxing on the body, the impact on skeletal muscles is reversible in the short term.

What Problem Does This Paper Address?

Cystic fibrosis is a chronic respiratory disease that also affects other organ systems, including skeletal muscles. Previous research has established that skeletal muscle weakness is a common complication in CF, often linked to reduced exercise capacity and physical activity. However, the specific impact of acute exacerbations – periods of worsening symptoms – on muscle strength and daily movement in CF patients remained largely unstudied. This paper aims to fill that gap by quantifying these changes during and after an exacerbation and comparing them to stable CF patients. Understanding this dynamic is crucial for managing the long-term health and quality of life for individuals with CF.

Methods

The researchers employed a prospective, observational study design. They recruited adult CF patients admitted with an acute exacerbation and measured their skeletal muscle strength and physical activity at three time points: within 48 hours of admission, at discharge, and one month post-discharge. For comparison, they also recruited a cohort of stable CF outpatients.

Key measurement techniques included:

  • Skeletal Muscle Strength:
    • Quadriceps Maximum Voluntary Contraction (QMVC): Measured using a strain gauge while patients attempted to extend their dominant leg.
  • Handgrip Strength: Assessed using a Jamar Handheld dynamometer.
  • Respiratory Muscle Strength: Measured via maximum sniff nasal inspiratory pressure (SNiP) and static expiratory and inspiratory mouth pressures (PEmax and PImax).
  • Physical Activity:
    • SenseWear Armband: A multi-sensor accelerometer worn on the upper arm to estimate total energy expenditure (TEE), physical activity duration (PAD), average metabolic equivalents (METs), active energy expenditure (AEE), number of steps, and sleep duration.
  • e-AR Monitor: A novel, ultra-lightweight, ear-worn activity recognition sensor that measures acceleration data. This device was used to calculate an "activity index" (AI).

Statistical analysis involved repeated measures ANOVA to assess changes over time and unpaired t-tests or Chi² tests for comparisons between groups.

Datasets

The study utilized data collected from:

  • 17 patients admitted with acute exacerbations of CF. Data was available at admission (n=17), discharge (n=16), and one month follow-up (n=13).
  • 25 stable CF outpatients for comparison.

The study did not introduce new public datasets but rather collected primary data from these patient cohorts.

Key Insights and Ideas

  • Quadriceps strength takes a hit during exacerbations: The most striking finding is the significant reduction in quadriceps strength during acute exacerbations, comparable to what's seen in COPD exacerbations. This highlights how systemic illness can directly impact peripheral muscle function.
  • Recovery is possible: Importantly, this muscle weakness appears to be reversible, with strength returning to baseline levels (comparable to stable patients) within one month post-exacerbation. This offers a hopeful outlook for rehabilitation strategies.
  • Respiratory muscles are more resilient: Unlike quadriceps strength, respiratory muscle strength (specifically inspiratory measures) did not show significant changes during exacerbations. This suggests that the primary impact of exacerbations on muscle function is on limb muscles.
  • Physical activity dips, but recovers: Acute exacerbations were associated with a reduction in daily physical activity (measured by step count and energy expenditure). However, similar to muscle strength, physical activity levels also recovered to baseline by one month.
  • Inflammation and activity aren't direct correlates of strength loss: Despite exacerbations involving increased systemic inflammation (higher white cell count and CRP), the degree of strength reduction did not directly correlate with these markers or with the reduction in physical activity. This suggests that the mechanisms behind muscle weakness during exacerbations are complex and not solely driven by these factors.
  • Novel activity monitoring shows promise: The study successfully used and validated a novel ear-worn activity monitor (e-AR) against a more established device (SenseWear armband), demonstrating its potential for objective activity tracking in clinical settings.

Key Results

  • At admission, quadriceps maximum voluntary contraction (QMVC) was 16.7% lower than in the stable state.
  • QMVC increased significantly from admission to discharge (by a mean of 8.2%) and continued to increase by one month post-discharge.
  • Respiratory muscle strength (SNiP, PImax, PEmax) did not change significantly during the study period.
  • Daily step count was significantly reduced at admission compared to discharge and one month post-discharge, but the one-month value was comparable to the stable group.
  • The e-AR activity index correlated well with energy expenditure data from the SenseWear armband, supporting its utility.

Limitations and Future Work

  • Inferring the "fall": The study inferred the reduction in strength during exacerbation by comparing admission values to convalescent values, rather than directly measuring strength before the exacerbation. While this approach is common in similar studies, it's a limitation.
  • Small sample size for specific analyses: While the overall study size is reasonable, some analyses (e.g., correlations with demographic parameters or specific treatments) were limited by the number of participants.
  • Unclear mechanisms: The study could not definitively identify the specific mechanisms responsible for the reduction in QMVC during exacerbations, despite exploring inflammation and activity levels.
  • Future research: The authors emphasize the need for larger studies to further investigate the mechanisms behind this muscle weakness and to explore the role of factors like systemic inflammation, patient age, and potential corticosteroid use. They also suggest the impedance ratio (Z200/Z5) as a potential biomarker for quadriceps strength.

Summary updated

BibTeX
@article{wieboldt2012effect,
  author = {Jason Wieboldt and Louis Atallah and Julia L. Kelly and Dinesh Shrikrishna and Khin M. Gyi and Benny Lo and Guang Yang and Diana Bilton and Michael I. Polkey and Nicholas S Hopkinson},
  title = {{Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis}},
  journal = {Journal of Cystic Fibrosis},
  year = {2012},
  doi = {10.1016/j.jcf.2011.12.001},
}
Figure